Additionally, abnormal expression of HOXB13 has been detected in the development of leukemia, non-Hodkin’s Lymphoma, oral squamous cell carcinoma, glioma, colon, stomach and genitourinary cancers [17, 29–36]. This evidence concerns the gene HOXB13 and central nervous system cancer.